bullish
Fluence Corporation - Contrasting trends
SUMMARY
Fluence’s Q319 results reflected contrasting trends. Further delays to Custom Engineering Solutions (CES) contracts lead us to cut our forecasts again, but Smart Product Solutions (SPS) is on track. Significantly, Fluence secured two new large Aspiral deals in China – if these ramp up as we anticipate, SPS revenue could double to more than US$50m in FY20e. If we add this to the existing CES contract base, Fluence is close to the revenue run-rate it needs to reach EBITDA break-even and cash generation.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Edison Investment Research
Leading International Investment Research
Price Chart(Sign Up to Access)
- Fluence Corporation - Contrasting trends04 Nov 2019
x